No Data
No Data
Asia vets ISM6331, a pan-TEAD inhibitor for the treatment of mesothelioma, has received FDA IND approval.
Asia Vets' ISM6331, a broad-spectrum TEAD inhibitor, has been granted orphan drug designation by the FDA and authorized for clinical trials.
InSilico Smart submits an IPO prospectus to be listed in Hong Kong, co-sponsoring by Morgan Stanley and CICC
On March 27, 2024, InSilico Medicine Cayman TopCo (hereinafter referred to as “Insilico Intelligence”) from Hong Kong submitted a prospectus to the Hong Kong Stock Exchange to go public on the Hong Kong Main Board. This is another application after its submission expired on June 27, 2023.
IPO News | Insili Smart filed for the second time in 2023, revenue increased by 69.8%, and losses narrowed
The world's leading AI-driven biotech company Insisilicon Smart once again submitted a listing application to the Hong Kong Stock Exchange. Morgan Stanley and CICC are co-sponsors
Favored by many well-known institutions, AI biotech company British Silicon Intelligence has broken through an IPO
Click on the blue letters to follow us. Biotech is considered a star sector in the Hong Kong stock market. Leading companies such as Baekje Shenzhou (06160.HK), Junshi Biotech (01877.HK), and Genting Xinyao B (01952.HK) are also among investors' concerns. Recently, another biotech company, InSilico Medicine Cayman TopCo (hereinafter referred to as “British Silicon Intelligence”), submitted a listing application to the Hong Kong Stock Exchange. Morgan Stanley and CICC (03908.HK) are co-sponsors. It's worth mentioning that in addition to British Silicon Smart
British Silicon Smart IPO: Valuation increased nearly 16 times in four years, with Huaping and Qiming among shareholders
Leju Finance's Lan Lan Lan On June 27, British Silicon Intelligence submitted a prospectus at the Hong Kong Stock Exchange. Morgan Stanley and CICC are co-sponsors. According to Leju Finance's “Pre-Audit IPO”, British Silicon Intelligence is a world-leading AI biotechnology company that provides end-to-end efficient solutions in the pipeline development process. During the reporting period, British Silicon's smart revenue mainly came from drug discovery services and software solution services.
IPO News | AI biotech company British Silicon Smart Report The Hong Kong Stock Exchange cooperates with Fosun Pharmaceuticals (600196.SH) and Sanofi (SNY.US)
The Zhitong Finance App learned that according to the Hong Kong Stock Exchange's disclosure on June 27, British Silicon Intelligence submitted a listing application to the Hong Kong Stock Exchange, with Morgan Stanley and CICC as co-sponsors. According to the prospectus, British Silicon Intelligence is an AI biotechnology company that provides end-to-end efficient solutions in the pipeline development process. Its business covers the United States, Greater China, Canada and the Middle East.
No Data
No Data